Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

UPDATE 2-Mylan defends King deal amid investor concerns Generic drug maker Mylan Laboratories Inc. reaffirmed on Wednesday its planned \$3.37 billion purchase of King Pharmaceuticals Inc.
